Legal status
Legal status
CAS Number 1863066-03-8(racemate)
PubChem (CID) 119026010
ChemSpider 32055578
Chemical and physical data
Formula C21H29N3O3
Molar mass 371.5 g/mol
3D model (Jmol) Interactive image

AMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid[1] that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.[2][3][4]

Legal status

AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[5]

See also


  1. Akamatsu, Shigeki; Yoshida, Masashi (January 2016). "Fragmentation of synthetic cannabinoids with an isopropyl group or a tert-butyl group ionized by electron impact and electrospray". Journal of Mass Spectrometry. 51 (1): 28–32. doi:10.1002/jms.3722.
  2. "MA-CHMINACA". Cayman Chemical. Retrieved 21 July 2015.
  3. "MA-CHMINACA". Southern Association of Forensic Scientists. Retrieved 21 July 2015.
  4. Samuel D Banister; et al. (July 2016). "The pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues". ACS Chemical Neuroscience. doi:10.1021/acschemneuro.6b00137.
  5. "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Retrieved 21 July 2015.

This article is issued from Wikipedia - version of the 8/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.